{"id":"https://openalex.org/W4380082901","doi":"https://doi.org/10.1158/1538-7445.am2023-5509","title":"Abstract 5509: The PI3K inhibitor Paxalisib combines synergistically with the MEK inhibitor Mirdametinib to target atypical teratoid/rhabdoid tumors","display_name":"Abstract 5509: The PI3K inhibitor Paxalisib combines synergistically with the MEK inhibitor Mirdametinib to target atypical teratoid/rhabdoid tumors","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4380082901","doi":"https://doi.org/10.1158/1538-7445.am2023-5509"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-5509","doi":"https://doi.org/10.1158/1538-7445.am2023-5509","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-5509","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052328478","display_name":"Kristen J. Malebranche","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristen J. Malebranche","raw_affiliation_strings":["1Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112751273","display_name":"Tyler Findlay","orcid":"https://orcid.org/0000-0001-5312-4881","observed_orcids":["https://orcid.org/0000-0001-5312-4881"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tyler Findlay","raw_affiliation_strings":["1Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009872562","display_name":"Anupa Geethadevi","orcid":"https://orcid.org/0000-0001-8087-1647","observed_orcids":["https://orcid.org/0000-0001-8087-1647"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anupa Geethadevi","raw_affiliation_strings":["1Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019028542","display_name":"Charles G. Eberhart","orcid":"https://orcid.org/0000-0002-2910-9427","observed_orcids":["https://orcid.org/0000-0002-2910-9427"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Eberhart","raw_affiliation_strings":["1Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049721824","display_name":"Eric H. Raabe","orcid":"https://orcid.org/0000-0002-9368-7037","observed_orcids":["https://orcid.org/0000-0002-9368-7037"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Raabe","raw_affiliation_strings":["1Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054848389","display_name":"Jeffrey A. Rubens","orcid":"https://orcid.org/0000-0002-8111-6114","observed_orcids":["https://orcid.org/0000-0002-8111-6114"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Rubens","raw_affiliation_strings":["1Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I145311948"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"5509","last_page":"5509"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.538100004196167,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.538100004196167,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.44530001282691956,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paxalisib","display_name":"paxalisib","score":0.968999981880188},{"id":"https://openalex.org/keywords/mirdametinib","display_name":"mirdametinib","score":0.9399999976158142},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.7960000038146973},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8389999866485596},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.871999979019165},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.7870000004768372},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.7260000109672546},{"id":"https://openalex.org/keywords/orthotopic-xenograft-model","display_name":"orthotopic xenograft","score":0.7850000262260437},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.921999990940094},{"id":"https://openalex.org/keywords/cellular-senescence","display_name":"cellular senescence","score":0.9449999928474426},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6000000238418579},{"id":"https://openalex.org/keywords/brain-penetrant-drugs","display_name":"brain-penetrant drugs","score":0.7350000143051147},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.5569999814033508},{"id":"https://openalex.org/keywords/pediatric-low-grade-glioma","display_name":"pediatric low-grade glioma","score":0.4659999907016754}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.8377017974853516},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.7522310614585876},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6978076100349426},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.64438396692276},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5223346948623657},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5144844055175781},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.42979463934898376},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3294987678527832},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3045698404312134},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.08904343843460083},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-5509","doi":"https://doi.org/10.1158/1538-7445.am2023-5509","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-5509","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4380361593","https://openalex.org/W4282938945","https://openalex.org/W4282926992","https://openalex.org/W4393093585","https://openalex.org/W4399787735","https://openalex.org/W4380362712","https://openalex.org/W4362596924","https://openalex.org/W4281696838","https://openalex.org/W7141736832","https://openalex.org/W4393089654"],"abstract_inverted_index":{"Abstract":[0],"Atypical":[1],"teratoid/rhabdoid":[2,293],"tumors":[3,9,16,227],"(AT/RT)":[4],"are":[5,33],"aggressive":[6,145],"pediatric":[7,164],"brain":[8,15],"and":[10,88,135,137,166,179,184,191,208,234,250,311],"the":[11,57,109,140,144,177,229,246,286,299],"most":[12],"common":[13],"malignant":[14],"of":[17,56,73,86,108,117,139,147,175,206,248,298],"infancy.":[18],"The":[19,123,279],"four-year":[20],"event-free":[21],"survival":[22,43,91,136],"rate":[23],"is":[24,65,151],"only":[25],"37%.":[26],"For":[27],"patients":[28,45],"with":[29,46,200,285],"relapsed":[30,262],"AT/RT":[31,87,189,225],"there":[32],"limited":[34],"treatment":[35],"options,":[36],"but":[37],"precision":[38],"therapies":[39],"may":[40],"help":[41],"improve":[42],"for":[44,162,302],"this":[47],"deadly":[48],"disease.":[49],"We":[50,75,170],"have":[51],"previously":[52],"identified":[53],"strong":[54],"activation":[55,107,138,237],"PI3K-AKT-mTOR":[58],"(mTOR)":[59],"signaling":[60],"pathways":[61,181],"in":[62,82,131,159,222],"AT/RT.":[63,263],"Paxalisib":[64,78,183,197,249,282],"a":[66,114,128,152,255],"highly":[67],"brain-penetrant":[68],"PI3K":[69,280],"inhibitor":[70,156,281,288],"acting":[71],"upstream":[72],"mTOR.":[74],"find":[76,171],"that":[77,172],"slows":[79],"tumor":[80],"growth":[81,134,146,190],"orthotopic":[83,226],"xenograft":[84],"models":[85],"extends":[89],"median":[90],"from":[92],"40":[93],"to":[94,143,187,202,260,290],"54":[95],"days":[96],"(p=0.001,":[97],"log-rank":[98],"test).":[99],"RNASeq":[100],"after":[101],"mTOR":[102,178,233],"pathway":[103,112,121,126,141,236],"inhibition":[104,174],"identifies":[105],"reflexive":[106],"RAS-RAF-MEK-ERK":[110,124],"(MAPK)":[111,125],"as":[113,254],"possible":[115],"mechanism":[116],"therapy":[118,231,253,259],"resistance":[119],"(KEGG":[120],"analysis).":[122],"plays":[127],"pivotal":[129],"role":[130],"regulating":[132],"cell":[133,209],"contributes":[142],"numerous":[148],"cancers.":[149],"Mirdametinib":[150,185,201,251,289],"small,":[153],"allosteric":[154],"MEK":[155,287],"currently":[157],"used":[158],"clinical":[160],"trials":[161],"both":[163,176],"low-":[165],"high-grade":[167],"gliomas":[168],"(PD0325901).":[169],"dual":[173],"MAPK":[180,235],"by":[182,213,240],"synergize":[186],"reduce":[188],"viability":[192],"(Bliss":[193],"synergy":[194],"score":[195],"16.77).":[196],"also":[198],"combines":[199,283],"induce":[203],"high":[204],"levels":[205],"apoptosis":[207],"senescence":[210],"(as":[211,238],"determined":[212,239],"western":[214,241],"blot:":[215],"cPARP,":[216],"pRB,":[217],"P21,":[218],"P16).":[219],"Na\u00efve":[220],"treatments":[221],"mice":[223],"bearing":[224],"suggests":[228],"combination":[230,252,258],"decrease":[232],"blot).":[242],"These":[243],"data":[244],"support":[245],"use":[247],"promising":[256],"novel":[257],"treat":[261],"Citation":[264],"Format:":[265],"Kristen":[266],"J.":[267],"Malebranche,":[268],"Tyler":[269],"Findlay,":[270],"Anupa":[271],"Geethadevi,":[272],"Charles":[273],"Eberhart,":[274],"Eric":[275],"Raabe,":[276],"Jeffrey":[277],"Rubens.":[278],"synergistically":[284],"target":[291],"atypical":[292],"tumors.":[294],"[abstract].":[295],"In:":[296],"Proceedings":[297],"American":[300],"Association":[301],"Cancer":[303,322],"Research":[304],"Annual":[305],"Meeting":[306],"2023;":[307],"Part":[308],"1":[309],"(Regular":[310],"Invited":[312],"Abstracts);":[313],"2023":[314],"Apr":[315],"14-19;":[316],"Orlando,":[317],"FL.":[318],"Philadelphia":[319],"(PA):":[320],"AACR;":[321],"Res":[323],"2023;83(7_Suppl):Abstract":[324],"nr":[325],"5509.":[326]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-06-10T00:00:00"}